Home  »  News   »  Don’t Miss Out on this Buy-In Window for Kintara...

Don’t Miss Out on this Buy-In Window for Kintara Therapeutics Inc. (KTRA)

Let’s start up with the current stock price of Kintara Therapeutics Inc. (KTRA), which is $0.15 to be very precise. The Stock rose vividly during the last session to $0.1511 after opening rate of $0.1459 while the lowest price it went was recorded $0.14 before closing at $0.15.Recently in News on September 8, 2022, Kintara Therapeutics Announces Three Abstracts Have Been Accepted for the 2022 Society for Neuro-Oncology Annual Meeting. Kintara Therapeutics, Inc.(Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that three posters have been accepted for data presentation at the 2022 Society for Neuro-Oncology (SNO) Annual Meeting. The 2022 SNO Annual Meeting will be held from November 16 through November 20, 2022 in Tampa, Florida. You can read further details here

Kintara Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.8400 on 04/11/22, with the lowest value was $0.1359 for the same time period, recorded on 09/08/22.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Kintara Therapeutics Inc. (KTRA) full year performance was -88.46%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Kintara Therapeutics Inc. shares are logging -90.20% during the 52-week period from high price, and 10.38% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.14 and $1.53.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 975242 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Kintara Therapeutics Inc. (KTRA) recorded performance in the market was -70.59%, having the revenues showcasing -36.84% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 10.40M, as it employees total of 4 workers.

Specialists analysis on Kintara Therapeutics Inc. (KTRA)

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.1994, with a change in the price was noted -0.14. In a similar fashion, Kintara Therapeutics Inc. posted a movement of -48.28% for the period of last 100 days, recording 3,221,903 in trading volumes.

Trends and Technical analysis: Kintara Therapeutics Inc. (KTRA)

Raw Stochastic average of Kintara Therapeutics Inc. in the period of last 50 days is set at 5.34%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 29.68%. In the last 20 days, the company’s Stochastic %K was 26.67% and its Stochastic %D was recorded 33.39%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -70.59%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -59.26%, alongside a downfall of -88.46% for the period of the last 12 months. The shares increased approximately by -7.01% in the 7-day charts and went up by -10.02% in the period of the last 30 days. Common stock shares were lifted by -36.84% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts